Administration of neutral endopeptidase to treat inflammatory bowel disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20060029590A1
SERIAL NO

11149513

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Administration of recombinant, truncated mammalian NEP or certain bacterial homologues of this protein is therapeutically effective in the treatment of inflammatory bowel disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CATALYST BIOSCIENCES INC611 GATEWAY BLVD SUITE 120 SOUTH SAN FRANCISCO CA 94080

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Madison, Edwin South San Francisco, CA 3 37
Thanos, Christopher San Francisco, CA 46 493

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation